CADTH Canadian Drug Expert Committee recommendation: Cysteamine delayed-release (Procysbi -- Horizon Pharma Ireland Ltd.) indication : nephropathic cystinosis
The Canadian Drug Expert Committee (CDEC) recommends that delayed-release cysteamine be reimbursed for treatment of nephropathic cystinosis
Corporate Authors: | , |
---|---|
Format: | eBook |
Language: | English |
Published: |
Ottawa (ON)
Canadian Agency for Drugs and Technologies in Health
2018, January 2018
|
Edition: | Version 1.0 |
Series: | CADTH common drug review
|
Subjects: | |
Online Access: | |
Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Summary: | The Canadian Drug Expert Committee (CDEC) recommends that delayed-release cysteamine be reimbursed for treatment of nephropathic cystinosis |
---|---|
Item Description: | "Final." |
Physical Description: | 1 PDF file (7 pages) |